Adam Bisaga, M.D.
Professor of Psychiatry at CUMC
Dr. Adam Bisaga is a Professor of Psychiatry at the Columbia University Medical Center, and a Research Scientist at the New York State Psychiatric Institute.
Dr. Bisaga received his medical degree from Jagiellonian University Medical College in Krakow, Poland. He completed his psychiatric residency at the North Shore University Hospital in Manhasset, NY and his addiction psychiatry fellowship at the Division of Substance Abuse at Columbia University. Here he received training in addiction psychiatry research under the mentorship of Drs. Marian Fischman and Herbert Kleber. Dr. Bisaga became a faculty at the Department of Psychiatry in 1999 and he was promoted to the rank of Professor in 2012.
Dr. Bisaga was a recipient of a Career Development Award and a Principal Investigator on several R01s and Center Grant Projects funded by the National Institute of Dug Abuse in the area of addiction pharmacotherapy development. His research interests include development of human laboratory and clinical trial models and testing medications to treat opioid, cocaine, and tobacco use disorders.
Besides his research contributions Dr. Bisaga’s has been actively involved in teaching medical students and practitioners. He is a Co-Director of an Addiction Psychiatry Fellowship and he is directing a Mentoring Program to train physicians in medication-assistant treatment of addictions (PCSS-MAT). He has been working with UN Office of Drug Control on the development of substance abuse treatment guidelines and conducted trainings for addiction practitioners internationally. In addition to the research and teaching work at the University, Dr. Bisaga also maintains a private practice in addiction psychiatry.
Medical School: Jagiellonian University Medical College, M.D., 1989
Internship: North Shore University Hospital, Medical, 1993 - 1994
Residency: North Shore University Hospital, Psychiatry, 1994 - 1997
Fellowship: Columbia University Medical Center/NYS Psychiatric Institute, Substance Abuse, 1997 - 1999
Board Certifications: American Board of Psychiatry & Neurology
Subspeciality Certifications: Addiction Psychiatry
• Addiction Psychiatry
• Substance Use Disorders
• Medication-Assisted Treatments
NYS Psychiatric Institute
Room 3711 Unit/Box:120
1051 Riverside Drive
New York, NY 10032
1. Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, Nunes EV: A randomized placebo controlled trial of gabapentin for cocaine dependence. . Drug Alcohol Depend 2006;81: 267-274
2. Bisaga A, Daysz W, Foltin R: Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder. . Eur. Neuropsychopharmacology 2008;18: 794-802
3. Bisaga A, Aharonovich E, Cheng W, Levin FR, Mariani JM, Raby WN, Nunes EV.: A placebo controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period.. Drug Alcohol Depend 2010;111: 97-104
4. Bisaga A, Sullivan MA, Cheng W, Carpenter KM, Mariani JM, Levin FR, Raby WN, Nunes EV. : A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence.. Drug Alcohol Depend 2011;119: e23-9
5. Bisaga A, Sullivan MA, Glass A, Mishlen K, Carpenter KM, Mariani JJ, Levin FR, Nunes EV.: A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence. J Subst Abuse Treat 2014;46: 546-52